Australia’s CSL Watches China Closely As Rival Baxter Tripped Up
This article was originally published in PharmAsia News
Executive Summary
Australia human plasma maker CSL Ltd. said it is closely monitoring crucial China operations after rival Baxter International discovered code of conduct violations at its China unit and launched an internal investigation.